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Abstract
Background: Of the 9.2 million new TB cases occurring each year, about 10% are in children.
Because childhood TB is usually non-infectious and non-fatal, national programs do not prioritize
childhood TB diagnosis and treatment. We reviewed data from a demonstration project to learn
more about the epidemiology of childhood TB in Thailand.
Methods: In four Thai provinces and one national hospital, we contacted healthcare facilities
monthly to record data about persons diagnosed with TB, assist with patient care, provide HIV
counseling and testing, and obtain sputum for culture and susceptibility testing. We analyzed clinical
and treatment outcome data for patients age < 15 years old registered in 2005 and 2006.
Results: Only 279 (2%) of 14,487 total cases occurred in children. The median age of children was
8 years (range: 4 months, 14 years). Of 197 children with pulmonary TB, 63 (32%) were
bacteriologically-confirmed: 56 (28%) were smear-positive and 7 (4%) were smear-negative, but
culture-positive. One was diagnosed with multi-drug resistant TB. HIV infection was documented
in 75 (27%). Thirteen (17%) of 75 HIV-infected children died during TB treatment compared with
4 (2%) of 204 not known to be HIV-infected (p < 0.01).
Conclusion: Childhood TB is infrequently diagnosed in Thailand. Understanding whether this is
due to absence of disease or diagnostic effort requires further research. HIV contributes
substantially to the childhood TB burden in Thailand and is associated with high mortality.
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Background
TB causes 9.2 million illnesses and 1.7 million deaths
annually [1]. About 10% of these TB cases occur in chil-
dren, i.e., persons less than 15 years old [2-4]. In most
countries, national TB programs (NTPs) focus case finding
and treatment on pulmonary, acid-fast bacilli (AFB)
smear-positive cases, which can be rapidly and reliably
diagnosed and contribute greatest to community TB trans-
mission [5]. Because most childhood TB cases are not
smear-positive, children are given lower priority in NTPs.
Historically, TB surveillance systems in high-burden
countries only recorded age categories for smear-positive
cases; as a result, few NTPs have been able to report relia-
bly the total number of childhood TB cases diagnosed and
treated annually [3]. The World Health Organization
(WHO) recommends TB disease screening in children
who live in the household of a smear-positive case, but
few NTPs perform this routinely [6].
Despite the lack of attention paid by NTPs, childhood TB
is an important public health problem. Because most chil-
dren have primary, rather than reactivation, disease, child-
hood TB is considered a "sentinel" event, indicating recent
TB transmission, often from an infectious, undiagnosed
TB case in the same household [7]. Identifying and treat-
ing TB infection and disease in children can also provide
long-term benefits to TB control, preventing future cases
due to reactivation [7]. The global HIV pandemic has
accelerated the urgency of TB control in children. Rates of
childhood TB appear to be rising, particularly in countries
with generalized HIV epidemics [3]. Multiple studies from
sub-Saharan Africa have documented a markedly
increased mortality rate for HIV-infected children with TB
compared to HIV-uninfected children with TB or to HIV-
infected children without TB [8-12].
WHO has recently called for more studies to define the
global epidemiology of childhood TB, because the litera-
ture remains scant, dominated primarily by studies from
industrialized countries and South Africa [13]. Few epide-
miologic studies of pediatric TB have been published
from Asia. Thailand is among the 22 high-burden TB
countries on WHO's list and has a generalized HIV epi-
demic [1]. Notification rates for childhood TB in Thailand
are markedly lower than in other countries; in fact, the
proportion of all reported TB cases that occur in children
(2.7%) is the lowest of the 22 high-burden countries [3].
We analyzed data from a multi-province demonstration
project to understand characteristics, treatment outcomes,




The Thailand TB Active Surveillance Network is a demon-
stration project, implemented by the Thailand Ministry of
Public Health (MOPH), Bangkok Metropolitan Adminis-
tration (BMA), U.S. Centers for Disease Control and Pre-
vention (CDC), and Research Institute of Tuberculosis,
Japan (RIT), involving all districts in three provinces (Chi-
ang Rai, Phuket, Ubon-ratchathani), selected districts in
Bangkok (2 in 2005; 9 in 2006), and one national infec-
tious diseases hospital (Bamrasnaradura Institute). In
2006, the catchment area included 59 public and 26 pri-
vate healthcare facilities. In 2005, the last year for which
published population estimates were available, the esti-
mated number of persons aged 0 – 14 years old in the
catchment area was 743,574, including 218,012 aged 0–4
years and 525,562 aged 5–14 years; for this calculation,
we excluded the national infectious diseases hospital
because this referral facility has no definable catchment
area (unpublished data, Thailand National Statistics
Department and BMA Office). A detailed description of
this project, including methods, has been published else-
where [14].
TB diagnosis
Thai national guidelines recommend that childhood pul-
monary TB (PTB) be diagnosed using a combination of
factors, including: history of contact with a PTB patient
known to be sputum smear-positive for acid-fast bacilli
(AFB); suspected TB symptoms and signs; an abnormal
chest radiograph, including pulmonary infiltrates and/or
hilar or mediastinal lymphadenopathy; sputum or gastric
aspirates that are smear-positive; and tuberculin skin test-
ing. Because this project relied on data collected as part of
routine TB control and most cases occurred in adults, lim-
ited information was collected about diagnostic tests
other than chest radiography, sputum microscopy, and
sputum culture. We did not collect data about tuberculin
skin testing. Gastric aspirate specimens were classified as
sputum specimens, in accordance with the routine TB pro-
gram practice of classifying patients with abnormal chest
radiographs and AFB-positive gastric aspirates as having
smear-positive, pulmonary TB. In Thailand, criteria for
EPTB diagnosis are less clearly delineated.
All public hospitals are able to process sputum for AFB
smear microscopy. As part of this demonstration project,
physicians were encouraged to send sputum specimens
for mycobacterial culture at a province-level facility. All
specimens were initially cultured on solid media, either
Lowenstein-Jensen (LJ) or Ogawa medium, and, during
mid-2005, additionally on liquid media with an auto-
mated reading instrument (Mycobacterial Growth Indica-
tor Tube [MGIT]; BACTEC 960, Becton-Dickinson
Corporation). Isolates underwent drug-susceptibility test-BMC Infectious Diseases 2008, 8:94 http://www.biomedcentral.com/1471-2334/8/94
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ing (DST) against first-line drugs (streptomycin, isoni-
azid, rifampin, pyrazinamide, ethambutol) at the
Bangkok municipal or national TB reference laboratories.
A case of childhood TB was defined as a person aged 0 –
14 years old who was diagnosed with TB and treated for
TB disease. A "new" case of TB was considered TB disease
in a person who reported no or less than 1 month of pre-
vious TB treatment.
TB treatment
Thai national guidelines recommend standardized, inter-
nationally-accepted treatment regimens for children.
Treatment outcomes were defined using standard WHO
categories [4].
HIV diagnosis and treatment
In this demonstration project, nurses and physicians from
public and private healthcare facilities were trained in HIV
counseling and testing. They were encouraged to provide
HIV counseling and testing to TB patients and referrals to
HIV-related care and treatment to HIV-infected TB
patients. No financial incentives were provided to patients
or healthcare workers for HIV testing. Individual physi-
cians used their own judgment about whether to measure
CD4+ T-cell lymphocyte counts (CD4), provide opportun-
istic infection (OI) prophylaxis or anti-retroviral therapy
(ART), and manage other clinical conditions. When per-
formed, blood for CD4 counts was usually drawn during
the first month of TB treatment.
Data collection and analysis
Data were collected on standardized forms that include
questions about demographics, clinical history, labora-
tory and radiographic testing, TB treatment regimens, TB
treatment outcomes, and HIV-related information (infec-
tion status, CD4, use of OI prophylaxis or ART). Data were
analyzed using the Statistical Package for Social Sciences
(SPSS) for Windows, version 12 software (SPSS Inc., Chi-
cago, IL, USA) for analysis. Rates of childhood TB (per
100,000) were determined from surveillance data and
population estimates; when calculating rates, we excluded
reports from the national infectious diseases hospital,
which has no population denominator. We classified age
as 0–4 and 5–14 consistent with international recommen-
dations [13]. Differences between groups were compared
with X2 test for categorical variables within different age
groupings; where appropriate, Fisher's exact test was used.
Statistical significance was defined as p < 0.05. Factors sig-
nificant in univariate analysis or factors likely to be asso-
ciated with outcomes were included in multivariate
models using logistic regression, and automated back-
ward, stepwise logistic regression was used to construct
final models. We calculated odds ratios (OR), adjusted
OR (AOR) and 95% confidence intervals (CI).
Ethical review
The protocol for this demonstration project was reviewed
by the Thailand MOPH and CDC and found to be surveil-
lance and public health program implementation not
requiring oversight by a human subjects research institu-
tional review board.
Results
Case finding and incidence
From October 2004 to September 2006, 14,487 TB cases
were recorded in surveillance. Of these, 279 (2%) cases
occurred in children, including: 56 (20%) pulmonary,
smear-positive; 103 (37%) pulmonary, smear-negative;
38 (14%) pulmonary, smear not known or done; and 82
(29%) extra-pulmonary. Lymph nodes were the most
common extra-pulmonary site (Table 1). Most (78%)
were registered as new cases. From October 2004 to Sep-
tember 2005, the incidence per 100,000 for all new TB
cases was 14 for children, 12 for age 0–4, and 14 for age
5–14. For pulmonary TB, the incidence per 100,000 was
10 (3 smear-positive) for all children, 8 (1 smear-positive)
for age 0–4, and 10 (3 smear-positive) for age 5–14. For
extra-pulmonary TB, the incidence per 100,000 was 5 for
age 0–4, and 4 for age 5–14.
Of 74 children aged 0–4, 8 (11%) had pulmonary, smear-
positive TB, compared with 48 (23%) of 205 children
aged 5–14 (p < 0.01). The proportion with EPTB and sites
involved did not differ by age group.
Characteristics of cases
The median age was 8 years, and only 9 (3%) were
younger than 1 year (Table 1). Half were male. Non-Thais,
e.g., migrants, refugees, visitors, or other foreigners,
accounted for 13% of cases. Only 2% of cases were diag-
nosed at a private facility. Previous treatment for TB dis-
ease was documented in 17 (6%) and for latent TB
infection in 12 (4%). Almost half (43%) had cough last-
ing more than 2 weeks, and most (69%) had abnormal
chest radiographs.
Of 197 pulmonary TB cases, 159 (81%) had at least one
sputum smear performed, and 79 (50%) of these had at
least one sputum culture performed. Of cases with a cul-
ture performed, 41 (52%) were culture-positive for Myco-
bacterium tuberculosis. Overall, 34 (17%) of the pulmonary
TB cases were smear-positive and culture-positive, 22
(11%) were only smear-positive (4 culture-negative; 5 cul-
ture not done; 4 culture-positive for non-tuberculous
mycobacterium [NTM]; and 9 culture unknown/missing),
134 (68%) were neither smear nor culture positive (24
culture-negative; 38 culture not done; 15 neither smear
nor culture done; 57 culture unknown/missing), and 7
(4%) were smear-negative and culture-positive. Of 41 cul-
ture-positive cases, 33 (80%) had DST performed. MDRBMC Infectious Diseases 2008, 8:94 http://www.biomedcentral.com/1471-2334/8/94
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Table 1: Characteristics of 279 childhood TB patients reported in the Thailand TB active surveillance network, October 2004 to 
September 2006
Characteristic Patients No. (%)
Type, anatomic site of TB
Smear-positive, pulmonary 56 (20)
Smear-negative, pulmonary 103 (37)













Treatment after default 3 (1)
Transfer in 9 (3)
Other 46 (17)
Median age (years) (range) 8 (4 months-14 years)
Age group (years)





Non-Thai nationality 36 (13)
Mobile within the past 6 months 64 (23)
Median number of persons living in home, persons (range) 4 (1–170)
Median number of additional children < 5 years old living in home, persons (range) 0 (0–10)
Previously treated for TB 17 (6)
Previously treated with isoniazid for latent TB infection 12 (4)
Cough lasting > 2 weeks at time of diagnosis 121 (43)
Living in migrant or refugee camp 1 (0)
Facility that made TB diagnosis
Private hospital 6 (2)
Government hospital or clinic 272 (98)
Unknown 1 (0)
Facility that provided TB treatment
Private hospital 5 (2)




Not performed 31 (11)
Unknown 40 (14)
Abnormal 192 (69)
Presence of a cavity 16 (6)
Microbiological characteristics of pulmonary TB cases
Smear-positive and culture-positive 34 (17)
Smear-positive and culture-negative or culture not done 22 (11)
Smear-negative and culture-positive 7 (4)
Neither smear- nor culture-positive 134 (68)
Initial treatment prescribed
CAT I (2HRZE/4HR) 164 (59)
CAT II (2HRZES/1HRZ/4HR) 8 (3)
CAT III (2HRZ/4HR) 84 (30)
CAT IV (2HRZS/4HR) 8 (3)
Other/missing 15 (5)
Observer assigned during first 2 months of treatmentBMC Infectious Diseases 2008, 8:94 http://www.biomedcentral.com/1471-2334/8/94
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TB was diagnosed in 1, which was 0.5% of all 197 pulmo-
nary TB cases and 3% of the 33 culture-positive cases that
had DST performed.
TB/HIV
Of 279 TB cases, 68 (24%) had known HIV status before
their diagnosis of TB. Of the remaining 211 cases with
unknown HIV status, 148 (53%) underwent HIV coun-
seling; 108 (73%) of those counseled agreed to HIV test-
ing. In all, 75 (27%) cases were known to be HIV-infected
(55 or 73% of whom knew their HIV status before TB
diagnosis), 102 (37%) were known to be HIV-uninfected,
and 102 (37%) had unknown HIV status.
Of the 75 HIV-infected TB patients, 21 (28%) were pul-
monary, smear-positive; 32 (43%) smear-negative; 7
(9%) smear not known or done and 15 (20%) extra-pul-
monary. Most (77%) were new cases. Half were male, and
81% were more than 5 years old. CD4 counts were avail-
able for 46 (61%) cases. The median was 55 (range: 2;
2731) and mean 193 cells/mm3. The distribution of CD4
was similar in those 0–4 years old (in whom absolute
CD4 is known to be unreliable) compared with those
5–14 years old. Only 6 (16%) of children aged 5–14 years
had CD4 greater than 200 cells/mm3. ART was prescribed
to 17 (23%) before the diagnosis of TB and to 16 (21%)
during TB treatment. ART was not prescribed to 18 (24%)
and was not known for 24 (32%). Of 32 HIV-infected
children aged 5–14 years who had CD4 less than 200
cells/mm3, 20 (62%) received ART. Among children
receiving ART, about half (45%) received a combination
regimen of stavudine, lamivudine, and nevirapine. Rates
of co-trimoxozole use were higher than ART; 23 (31%)
were taking co-trimoxazole before their diagnosis of TB,
and 21 (28%) were prescribed co-trimoxazole during TB
treatment. Almost all (97%) children with CD4 less than
200 cell/mm3 received co-trimoxazole.
Treatment outcomes
Of all 279 patients, 200 (72%) were cured or completed
TB treatment, 17 (6%) died during TB treatment, 3 (1%)
failed treatment, 39 (14%) defaulted, and 20 (7%) trans-
ferred out (Table 1). We stratified outcomes by age group
and HIV status (Table 2). More defaults occurred in chil-
dren aged 0–4 (16/74, 22%) than in children aged 5–14
(23/205, 11%), (p < 0.02). No deaths occurred in the 74
children aged 0–4, compared with 17 (8%) deaths in the
205 children aged 5–14 (p = 0.03). Of the 17 deaths, 13
were in patients with pulmonary TB (2 culture-positive
and smear-negative, 5 smear-positive only, 6 neither
smear- nor culture-positive) and 4 were in extra-pulmo-
nary TB (2 lymph node, 2 not known). Thirteen (76%)
deaths occurred in HIV-infected children; of the nine with
CD4 recorded, all had CD4 < 65 cells/mm3.
We also stratified treatment outcomes by anatomic site
and/or microbiologic characteristics (Table 3). In children
with extra-pulmonary TB, treatment success rates were
highest in patients with lymph node TB (86%). Of
patients with meningitis, 67% had unknown outcomes (6
defaulted; 7 transferred out). All 13 patients with
unknown outcome were from one province that borders
Burma and has a large population of migrant Thais and
non-Thais; 8 (62%) of these were non-Thai migrants. In
children with pulmonary TB, treatment success rates were
not significantly different when we stratified cases by
microbiologic characteristics.




Offered HIV counseling after diagnosis of TB
Yes 148 (53)
No 46 (17)






Among pulmonary smear-positive patients, sputum converted to smear-negative after 2 months of treatment 36 (64)
Treatment outcome




Transferred out 20 (7)
Table 1: Characteristics of 279 childhood TB patients reported in the Thailand TB active surveillance network, October 2004 to 
September 2006 (Continued)BMC Infectious Diseases 2008, 8:94 http://www.biomedcentral.com/1471-2334/8/94
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Factors associated with death or default
In univariate and multivariate analysis comparing
patients who died with those successfully treated, factors
statistically associated with death were treatment at the
national infectious diseases hospital (aOR 7.3; CI,
1.3–41.6, compared with treatment at other sites), and
being HIV-infected (aOR 6.9; CI, 1.4–33.0, compared
with HIV-uninfected). No children aged less than 5 years
died compared with 17% of children aged 5 – 14 years
(Table 4). In univariate and multivariate analysis compar-
ing patients who defaulted with those successfully treated,
factors statistically associated with default were being
non-Thai (aOR 5.8; CI, 2.3–14.8) compared with being
Thai (Table 5).
Discussion
We found that childhood TB is infrequently diagnosed in
Thailand. In our population, the rate of childhood TB was
14 cases per 100,000, consistent with one published esti-
mate, derived from the WHO global report, of childhood
TB incidence in Thailand (15 cases per 100,000 children)
[3]. The rate of smear-positive TB in our population was
much higher (3 per 100,000 versus 1 per 100,000) than
routine national surveillance data. There are at least two
possible explanations for the higher case detection rate in
our project compared with national surveillance. First,
national surveillance may not sufficiently capture all diag-
nosed cases of TB. Our demonstration project involved
contacting healthcare facilities regularly to ascertain diag-
nosed cases of TB; it is likely that we identified cases of TB
that would not normally have been reported [14]. Second,
and conversely, our surveillance sites may over-estimate
the overall burden of childhood TB in Thailand, because
the participating provinces have higher TB and HIV prev-
alence rates than the national average and have enhanced
TB laboratory capacity. Enhancing the national surveil-
lance system to collect age data for all forms of TB, to dif-
ferentiate between children aged 0–4 and 5–14, to collect
microbiological characteristics of pulmonary TB cases,
and to integrate HIV-related data would permit more
detailed analysis and better define the burden of child-
hood TB in Thailand. We found a low rate of extra-pulmo-
nary TB compared to other reports [4]. It is possible that
high coverage of BCG vaccination can prevent invasive TB
disease. We did not collect data on history of BCG vacci-
nation or BCG scar; however, national coverage of BCG
vaccine in 2006 was more than 99% [15].
Table 2: Treatment outcomes for childhood TB cases, stratified by age group and HIV status, in Thailand TB active surveillance 
network, October 2004 to September 2006
Age (years) HIV status Total Treatment outcome No. (%) registered
Cured or completed Failed Died Defaulted Transferred out
0–4 Positive 14 12 (86) 0 (0) 0 (0) 2 (14) 0 (0)
Negative 30 16 (53) 0 (0) 0 (0) 9 (30) 5 (17)
Unknown 30 23 (76) 0 (0) 0 (0) 5 (17) 2 (7)
5–14 Positive 61 37 (61) 0 (0) 13 (21) 7 (11) 4 (7)
Negative 72 52 (72) 3 (4) 2 (3) 10 (14) 5 (7)
Unknown 72 60 (83) 0 (0) 2 (3) 6 (8) 4 (6)
Total 279 200 (72) 3 (1) 17 (6) 39 (14) 20 (7)
Table 3: Treatment outcomes for childhood TB cases, categorized by anatomic site and/or microbiologic characteristics, in Thailand 
TB active surveillance network, October 2004 to September 2006
Diagnosis Total Treatment outcome No. (%) registered
Cured or completed Failed Died Defaulted Transferred out
All types of TB 279 200 (72) 3 (1) 17 (6) 39 (14) 20 (7)
Pulmonary 197 144 (73) 3 (1) 13 (7) 26 (13) 11 (6)
Neither smear nor culture Positive 134 99 (74) 1 (1) 6 (4) 19 (14) 9 (7)
Culture or smear positive 41 32 (78) 1 (2) 2 (5) 4 (10) 2 (5)
Smear positive only 22 13 (59) 1 (4) 5 (23) 3 (14) 0 (0)
Lymph node 42 36 (86) 0 2 (5) 4 (9) 0
Meningitis 21 8 (38) 0 0 6 (29) 7 (33)
Other types of ETB 19 12 (63) 0 2 (10) 3 (16) 2 (10)BMC Infectious Diseases 2008, 8:94 http://www.biomedcentral.com/1471-2334/8/94
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Unfortunately, measuring the true burden of childhood
TB in any country is extremely difficult, because no diag-
nostic test performs well in childhood TB. Most children
cannot expectorate sputum and/or have pauci-bacillary
pulmonary TB. Gastric aspiration and sputum induction,
although validated, are used mainly in academic or big
referral hospitals and are infrequently used in small hos-
pitals because of technical demands and relatively low
yield [16]. In our project, most cases were not bacteriolog-
ically-confirmed, consistent with data from both low- and
high-burden TB countries [6]. International guidelines
also instruct clinicians to use radiographic changes, tuber-
culin skin testing, symptoms, and contact with a known
TB case as clues to the diagnosis [7]. Our enhanced sur-
veillance system did not record sufficient detail about
these characteristics and gastric aspiration to allow us to
assess the accuracy of TB diagnosis. Further, because con-
tact investigations are rarely performed in Thailand, many
childhood TB cases may have gone undiagnosed in the
community. A more detailed evaluation of clinical diag-
nostic and public health practices in Thailand is needed to
understand the accuracy of childhood TB diagnosis and
the relative contribution of diagnostic effort to differences
in reporting rates.
HIV contributes substantially to the burden of childhood
TB in Thailand. The minimum prevalence of HIV infec-
tion in children (27%) was similar to that in adults (31%)
recorded in our surveillance system (Thailand MOPH,
unpublished data). The HIV prevalence was higher in
older children than in younger children, likely because of
the effectiveness of Thailand's highly effective mother-to-
child HIV transmission that began in 2000 [17]. Almost
one-fifth of HIV-infected children with TB died during TB
treatment, all of them aged 5–14. The markedly advanced
immune-suppression in these children is identical to that
seen in HIV-infected Thai adults, in whom TB occurs
almost exclusively at low CD4 levels [14,18]. Our data
shows that despite national TB and HIV treatment guide-
lines, coverage of some key aspects of TB and HIV care was
low. As in adults, reducing TB morbidity and mortality in
HIV-infected children requires further integration of HIV
counseling and testing into TB services, ART and co-tri-
moxazole for HIV-infected TB patients, prevention of TB
through treatment of latent TB infection, and earlier diag-
nosis through contact investigations and routine screen-
ing for TB disease in HIV-infected children. Documenting
CD4 percentage, as well as absolute count, on TB registers
will assist in identifying when children aged less than 5
years should be receiving ART as well as TB treatment.
Data on childhood TB treatment outcomes is scarce. One
surprising finding was the high rate of default particularly
patients with meningitis. Most defaults occurred in non-
Table 4: Factors associated with death versus successful (cure or completed) outcome among childhood TB cases in Thailand, October 
2004 to September 2006
Characteristic No. died/total (%) Unadjusted OR (95% CI) Adjusted OR (95% OI)
Age (in years)
< 5 0/51 (0) - -
5–14 17/166 (10) -
Gender
Male 12/111 (11) 2.8 (0.8–9.7) -
Female 5/106 (5) Referent
Nationality
Non-Thai 1/15 (7) 1.0 (0.1–11.2) -
Thai 16/202 (8) Referent
Site
National infectious diseases hospital 4/8 (50) 7.4 (0.9–58.7) 7.3 (1.3–41.6)
Chiang Rai 6/104 (6) 0.8 (0.2–2.9) 0.8 (0.3–2.6)
Other 7/105 (7) Referent Referent
Diagnosis
Pulmonary, smear-positive 6/45 (13) 1.5 (0.4–6.0) -
Pulmonary, smear-negative 7/80 (9) Referent
Pulmonary, smear-unknown 0/32 (0) -
Extra-pulmonary TB 4/60 (7) 0.7 (0.1–3.4)
Registration status
New 15/167 (9) 1.6 (0.2–10.7) -
Previously treated 2/50 (4) Referent
HIV status
Positive 13/62 (21) 5.9 (1.2–30.1) 6.9 (1.4–33.0)
Negative 2/70 (3) Referent Referent
Unknown 2/85 (2) 0.9 (0.1–7.4) 0.7 (0.1–5.4)BMC Infectious Diseases 2008, 8:94 http://www.biomedcentral.com/1471-2334/8/94
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Thais, a heterogeneous group of 2.3 million people that
consist of economic migrants, refugees, visitors, and other
temporary residents [19]. Because rates of default are
known to be high in adult migrants with TB, our finding
is worrisome, albeit expected. Further efforts are needed to
maintain non-Thai adults and children on TB treatment to
prevent drug resistance.
Our study has important limitations, particularly its small
sample size and the absence of microbiologic confirma-
tion in most diagnosed patients. Its primary strength is
that it is the only population-based study that we know of
about childhood TB epidemiology and treatment out-
comes in Asia, a region that contributes to one-half of the
global TB burden. Our data confirm that the burden of
diagnosed childhood TB in Thailand is less than that in
other high-burden countries, but it is substantially greater
than national surveillance data indicate and is closely
associated with the HIV epidemic. Strengthening national
surveillance to capture all diagnosed cases of TB in chil-
dren, providing training or guidance to health care pro-
viders in community hospitals how to perform gastric
aspiration and to record more detailed data about child-
hood TB cases will help provide more accurate estimates
of the national disease burden and potentially increase
political commitment to address childhood TB. Reducing
morbidity and mortality from TB in Thai children will
require enhancing laboratory capacity for microbiologic
confirmation of disease, increasing TB screening in house-
hold contacts and HIV-infected children, strengthening
linkages to HIV-related services, and reducing default
rates.
Conclusion
Childhood TB is infrequently diagnosed in Thailand.
Understanding whether this is due to absence of disease
or diagnostic effort requires further research. Strengthen-
ing national surveillance to capture all diagnosed cases of
TB in children will help provide more accurate estimates
of the national disease burden and potentially increase
political commitment to address childhood TB. HIV con-
tributes substantially to the childhood TB burden in Thai-
land and is associated with high mortality. Reducing
morbidity and mortality from TB in Thai children will
require enhancing laboratory capacity for microbiologic
confirmation of disease, increasing TB screening in house-
hold contacts, reducing default rates and strengthening
linkages to HIV-related services for HIV-infected children.
Table 5: Factors associated with default versus successful (cure or completed) outcome among childhood TB cases in Thailand, 
October 2004 to September 2006
Characteristic No. defaulted/total (%) Unadjusted OR (95% CI) Adjusted OR (95% OI)
Age (in years)
< 5 16/67 (24) 2.0 (0.9–4.5) 2.0 (0.9–4.5)
5–14 23/172 (13) Referent Referent
Gender
Male 23/122 (19) 1.5 (0.7–3.3) -
Female 16/117 (14) Referent
Nationality
Non-Thai 13/27 (48) 6.3 (2.3–16.8) 5.8 (2.3–14.8)
Thai 26/212 (12) Referent Referent
Site
National infectious diseases hospital 1/5 (20) 0.6 (0.0–9.2) 0.6 (0.0–8.7)
Chiang Rai 25/123 (20) 0.5 (0.1–1.5) 0.5 (0.2–1.6)
Phuket 1/25 (4) 0.1 (0.0–1.0) 0.1 (0.0–1.1)
Ubon-ratchathani 5/58 (9) 0.3 (0.1–1.3) 0.3 (0.1–1.4)
Bangkok 7/28 (25) Referent Referent
Diagnosis
Pulmonary, smear-positive 7/46 (15) 0.5 (0.2–1.6) -
Pulmonary, smear-negative 14/87 (16) Referent
Pulmonary, smear-unknown 5/37 (13) 1.9 (0.3–11.2)
Extra-pulmonary TB 13/69 (19) 1.0 (0.4–2.7)
Registration status
New 32/184 (17) 2.1 (0.5–8.6) -
Previously treated 7/55 (13) Referent
HIV status
Positive 9/58 (15) 0.8 (0.3–2.1) 0.8 (0.3–2.1)
Negative 19/87 (22) Referent Referent
Unknown 11/94 (12) 0.3 (0.1–0.8) 0.4 (0.1–1.0)Publish with BioMed Central    and   every 
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